SCRSX
Price
$13.92
Change
-$0.07 (-0.50%)
Updated
Jul 31 closing price
Net Assets
839.68M
VSCIX
Price
$141.38
Change
-$0.34 (-0.24%)
Updated
Jul 31 closing price
Net Assets
188.57B
Interact to see
Advertisement

SCRSX vs VSCIX

SCRSX vs VSCIX Comparison Chart in %
View a ticker or compare two or three
VS
SCRSX vs. VSCIX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SCRSX is a Hold and VSCIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSCIX has more cash in the bank: 189B vs. SCRSX (840M). VSCIX pays higher dividends than SCRSX: VSCIX (1.23) vs SCRSX (0.29). SCRSX was incepted earlier than VSCIX: SCRSX (11 years) vs VSCIX (29 years). SCRSX (1.13) is less costly to investors than VSCIX (0.03). SCRSX is a more actively managed with annual turnover of: 97.00 vs. VSCIX (17.00). SCRSX has a lower initial minimum investment than VSCIX: SCRSX (5000) vs VSCIX (5000000). VSCIX annual gain was more profitable for investors over the last year : 22.58 vs. SCRSX (18.06). VSCIX return over 5 years is better than : 35.13 vs. SCRSX (-6.83).
SCRSXVSCIXSCRSX / VSCIX
Total Expense Ratio1.130.033,767%
Annual Report Gross Expense Ratio1.130.033,767%
Fund Existence11 years29 years-
Gain YTD19.69014.591135%
Front LoadN/AN/A-
Min. Initial Investment500050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets840M189B0%
Annual Yield % from dividends0.291.2324%
Returns for 1 year18.0622.5880%
Returns for 3 years7.5743.4417%
Returns for 5 years-6.8335.13-19%
Returns for 10 years39.94156.0726%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GSPKX20.050.12
+0.60%
Goldman Sachs US Eq Div and Prem Instl
GSIQX23.62N/A
N/A
Goldman Sachs GQG Ptnrs Intl Opps R
HSIIX29.59-0.08
-0.27%
Carillon Eagle Small Cap Growth I
CCWSX21.56-0.16
-0.74%
Baird Chautauqua International Gr Inv
RYCFX49.56-1.15
-2.27%
Rydex Biotechnology C